# GHK-Cu: A Signal Already in Your Plasma > GHK-Cu: Research Overview — Peptide Messengers — A literature summary of GHK-Cu, the copper-binding tripeptide the body already makes and carries less of with age — mechanism, tissue-repair evidence, real-world reports, and cited safety cautions. **03 / A COPPER-CARRYING MESSENGER** A three-amino-acid, copper-chelating peptide the body makes on its own — and makes less of as it ages — carrying the deepest cosmetic-dermatology trial record of any compound on this desk. ## The short version GHK-Cu is a tiny messenger: just three amino acids (glycine, histidine, lysine) wrapped tightly around a single copper ion. Unlike the other compounds here, it is not entirely synthetic — the GHK sequence occurs naturally inside human collagen, and GHK-Cu itself circulates in blood plasma, at levels that measurably decline with age. That natural presence is part of why it has the longest and best-documented cosmetic track record on this site. Topically applied Copper Tripeptide-1 is a legal, widely sold cosmetic ingredient with a genuine placebo-controlled evidence base for skin appearance. There is no FDA-approved injectable or oral drug form; using it that way is unapproved and effectively untested in humans. This page keeps those two very different use cases — topical cosmetic and injectable research use — clearly separated, because the evidence behind them is not remotely comparable. ## What it is GHK-Cu is a linear tripeptide (glycine-histidine-lysine) bound in a 1:1 ratio to a copper(II) ion through three coordination points, with the lysine side chain left free. The GHK sequence itself is found within type I collagen and a bone/connective-tissue protein called osteonectin, which is part of why researchers consider it an endogenous signal rather than a foreign molecule. As a messenger, its job is twofold: it acts as a copper chaperone, ferrying a metal ion cells need for several enzymes, and it directly signals tissue cells — chiefly skin fibroblasts — to synthesize repair proteins. ## How it works At very low concentrations, GHK-Cu prompts dermal fibroblasts to make more collagen, elastin, and the sugar-protein complexes (glycosaminoglycans, decorin) that give skin its structure, while rebalancing the enzymes that break that structure down against the enzymes that protect it. The bound copper ion itself does mechanistic work: it enables an enzyme (lysyl oxidase) that cross-links collagen and elastin fibers, and it has antioxidant, superoxide-dismutase-like activity of its own. At the gene level, the signal is broad. Analyses report that GHK shifts expression of roughly 31% of measured human genes at a 50%-or-greater change threshold, turning up wound-repair, DNA-repair, and antioxidant programs and turning down inflammatory signaling — a striking figure, though the popular claim of "4,000 genes" affected is an extrapolation beyond what the underlying data directly support [14]. ## What the research shows *Wrinkle and collagen evidence.* A 2025 review found topical GHK-Cu increased procollagen synthesis in 70% of treated subjects, versus 50% for vitamin C and 40% for retinoic acid in the same body of trials, while confirming that GHK's poor skin permeability is the central formulation challenge the field is still solving [13]. *Gene-expression breadth.* GHK modulates roughly 31.2% of measured human genes at a 50%-or-greater threshold — 59% up, 41% down — including strong activation of the cell's protein-quality-control (ubiquitin-proteasome) system and DNA-repair and antioxidant gene sets [14]. *Hair growth.* In a six-month trial of 45 men with male-pattern hair loss, a combination of a GHK-containing peptide and 5-aminolevulinic acid increased hair count by 52.6 to 71.5 versus 9.6 for placebo (statistically significant), with no adverse events reported in any group — though this tested a combination product, not pure GHK-Cu alone [15]. *Canonical skin-regeneration review.* A widely cited 2015 review documents that plasma GHK falls from roughly 200 ng/mL at age 20 to roughly 80 ng/mL by age 60, alongside the same 70%-versus-50%-versus-40% collagen-synthesis comparison against vitamin C and retinoic acid [16]. *Skin penetration.* A human skin study measured how much copper delivered as GHK-Cu actually gets through skin: over 48 hours, about 136 micrograms per square centimeter of copper permeated the skin and about 97 micrograms per square centimeter was retained as a depot in the dermis — the quantitative basis for how topical formulations are designed [17]. ## Reported effects, cautions & safety *Anecdotal, not clinical evidence* — the reports below are drawn from skincare-community discussion and product reviews, not controlled measurement, and none of them is a recommended dose. Firmer, tighter-feeling skin is the most commonly described benefit, usually building over several weeks of consistent twice-daily use rather than appearing overnight. Softer fine lines, better hydration and a plumper look (often the earliest change people notice), smoother texture, and a brighter overall complexion are all frequently mentioned. Some scalp users, often combining a copper-peptide serum with microneedling, describe less hair shedding and thicker-looking hair within a couple of months. A smaller group reports using GHK-Cu by injection in research contexts and describes subjective skin or recovery benefits — but these accounts sit entirely outside the well-documented topical evidence and have no validated human data behind them. On the adverse side, irritation — redness, itching, or a dry, tight feeling — is the most common complaint, usually linked in community guides to starting at too high a concentration or applying too often. A minority describe a short breakout or "purging" phase, or the so-called "copper uglies," where skin looks temporarily duller rather than better. A very common practical complaint is that copper peptides seem to lose effectiveness or cause irritation when layered with vitamin C or strong acids in the same routine. Cited safety cautions: injectable or other systemic use of GHK-Cu is unapproved and has no validated human pharmacokinetic basis — the closest data point is a rat study showing the free peptide breaks down quickly in blood. In principle, repeated systemic copper intake could disturb the body's copper-zinc balance, particularly relevant to anyone with a copper-handling condition, though no human copper-toxicity cases have been tied to GHK-Cu in the published record. Because copper feeds pigment-producing chemistry, people prone to melasma or dark spots may want to be cautious, since a laboratory study found a copper peptide raised pigment-cell activity. Skin irritation is more likely at high concentration or with sensitive skin. Combining GHK-Cu with vitamin C or strong acids in the same step can chemically break apart the copper complex and is a documented formulation-stability issue, not just a folk claim [13]. Most of the foundational GHK-Cu literature traces to one research group, which is a reason to treat the broadest anti-aging claims with some caution until more independent replication exists [13][16]. ## Where it fits among the messengers GHK-Cu is the one messenger on this desk the body already carries at measurable levels — a signal that declines with age rather than one introduced entirely from outside, the way [semaglutide](/semaglutide) or [PT-141](/pt-141) are. Its topical evidence is also the most human-tested and placebo-controlled of any compound here, even though its injectable use sits in the same unproven category as the others. See the full evidence-maturity comparison on the [comparison page](/compare). --- A reading desk for the body's own chemical signaling — not a clinic, not a vendor, and never the source of a dose.